Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
desktop iconMarkt Monitor

Esperite (voorheen Cryo Save)« Terug naar discussie overzicht

NEWS : Esperite upgrade Tranquility

257 Posts
Pagina: «« 1 2 3 4 5 6 ... 13 »» | Laatste | Omlaag ↓
  1. flosz 17 mei 2015 11:20
    GENDIA biedt de Harmony NIPT test aan, de enige gevalideerde NIPT test in België en Nederland.

    Harmony Test van de firma Ariosa (San Jose, CA, USA)
    Ariosa= Roche.

    Overige gebruikte NIPT testen in Duitsland, Engeland, Spanje, Portugal, USA, etc.( fabrikanten en prijzen):
    niptconsortium.nl/faq/
    www.downsyndromenipt.info/faq-items/h...
    www.downsyndromenipt.info/wp-content/...

    Patent battles
    www.fiercemedicaldevices.com/special-...

    Illumina sues UK's Premaitha over alleged patent infringement. US genome sequencing giant claims Premaitha's flagship test breaches two patents

    A small UK company that has recently launched a test to screen for Down's Syndrome in unborn babies is facing legal action from US gene sequencing giant Illumina over an alleged intellectual property breach.
    Premaitha has been accused of infringing two of Illumina's patents in its sole product, a test which estimates the risk of Down's, Edwards' and Patau's syndromes in unborn babies.
    The case relates to Premaitha's so-called Iona test, which detects the risk of genetic abnormalities by analysing traces of foetal DNA in the mother's blood.
    Premaitha on Monday morning annunced that Swiss laboratory group Genoma would offer the Iona test to its customers, in what Dr Little described as a "major milestone" for the company.
    www.telegraph.co.uk/finance/newsbysec...
  2. Vitavita 17 mei 2015 16:42
    quote:

    flosz schreef op 17 mei 2015 11:20:

    GENDIA biedt de Harmony NIPT test aan, de enige gevalideerde NIPT test in België en Nederland.

    Harmony Test van de firma Ariosa (San Jose, CA, USA)
    Ariosa= Roche.

    Overige gebruikte NIPT testen in Duitsland, Engeland, Spanje, Portugal, USA, etc.( fabrikanten en prijzen):
    niptconsortium.nl/faq/
    www.downsyndromenipt.info/faq-items/h...
    www.downsyndromenipt.info/wp-content/...

    In de medische diagnostiek wordt bij het kwalificeren van testen de volgende twee waarden gemeten: Sensitiviteit en Specifiteit.
    Volgens deze gemeten waarden zou de Tranquility-test het hoogst scoren in vergelijking met andere NIPT-testen zoals Ariosa, Natera en Sequenom.
  3. Vitavita 17 mei 2015 16:44
    quote:

    flosz schreef op 17 mei 2015 11:20:

    Patent battles
    www.fiercemedicaldevices.com/special-...

    Illumina sues UK's Premaitha over alleged patent infringement. US genome sequencing giant claims Premaitha's flagship test breaches two patents

    A small UK company that has recently launched a test to screen for Down's Syndrome in unborn babies is facing legal action from US gene sequencing giant Illumina over an alleged intellectual property breach.
    Premaitha has been accused of infringing two of Illumina's patents in its sole product, a test which estimates the risk of Down's, Edwards' and Patau's syndromes in unborn babies.
    The case relates to Premaitha's so-called Iona test, which detects the risk of genetic abnormalities by analysing traces of foetal DNA in the mother's blood.
    Premaitha on Monday morning annunced that Swiss laboratory group Genoma would offer the Iona test to its customers, in what Dr Little described as a "major milestone" for the company.
    www.telegraph.co.uk/finance/newsbysec...


    Het hierboven is deel één, deel twee is op 5 mei geschreven:

    Premaitha files robust defence with UK's High Court in response to alleged infringement of NIPT patents
    May 5, 2015

    Manchester, UK – 5 May 2015 – Premaitha Health plc ("Premaitha", AIM: NIPT) announces that it has filed a robust defence and counterclaim in the High Court of Justice, Chancery Division, Patents Court in the United Kingdom in connection with the patent infringement suit filed on 16 March 2015 by Illumina, Inc. and its wholly-owned subsidiary Verinata Health Inc.
    The patents in question are European Patent (UK) 0 994 963 B2 and European Patent (UK) 1 981 995 B1.

    Dr Stephen Little, CEO of Premaitha, said, "We have looked at the legal position very carefully and, in our view, the claims are without substance.
    "Within the UK and globally, it is vitally important that both expectant mothers and health care authorities have the freedom to make appropriate and informed choices. We believe our best-in-class IONA® test enables this choice to be made."

    www.fiercediagnostics.com/press-relea...

  4. flosz 18 mei 2015 11:57
    Ter aanvulling, @de liefhebber( oud maar interessant imho).

    www.rijksoverheid.nl/bestanden/docume...
    niptconsortium.nl/studies/

    Uit 2013
    prenatalescreeningzon.mumc.nl/sites/r...
    Panorama/Verify/MaterniT21 Plus/ Harmony/Nifty.

    NIPT Landscape Shifts in 2014 as Providers Transfer Technology, Plan IVDs
    (Art.01/2015): www.genomeweb.com/molecular-diagnosti...
257 Posts
Pagina: «« 1 2 3 4 5 6 ... 13 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.